Search

Ying Liu Phones & Addresses

  • San Francisco, CA

Professional Records

License Records

Ying Liu

License #:
31157 - Active
Issued Date:
May 17, 2013
Renew Date:
Dec 1, 2015
Expiration Date:
Nov 30, 2017
Type:
Certified Public Accountant

Ying Liu

License #:
14009 - Active
Issued Date:
Oct 5, 2012
Renew Date:
Jan 1, 2017
Expiration Date:
Dec 31, 2018
Type:
Massage Therapist

Ying Liu

License #:
0402036583
Category:
Professional Engineer License

Ying Liu

License #:
05195 - Active
Category:
Accountants
Issued Date:
Feb 22, 2010
Expiration Date:
Jun 30, 2018
Type:
Certified Public Accountant

Ying Liu

License #:
06149 - Active
Category:
Accountants
Issued Date:
Mar 8, 2012
Expiration Date:
Jun 30, 2018
Type:
Certified Public Accountant

Ying Liu

License #:
03922 - Expired
Category:
Accountants
Issued Date:
Feb 27, 2006
Expiration Date:
Jun 30, 2009
Type:
Certified Public Accountant

Ying Liu

License #:
05195 - Active
Category:
Accountants
Issued Date:
Feb 22, 2010
Expiration Date:
Jun 30, 2018
Type:
Certified Public Accountant

Ying Liu

License #:
06149 - Active
Category:
Accountants
Issued Date:
Mar 8, 2012
Expiration Date:
Jun 30, 2018
Type:
Certified Public Accountant

Medicine Doctors

Ying Liu Photo 1

Ying Liu

View page
Specialties:
Internal Medicine
Work:
John T Mather Memorial Hospital Internal Medicine Residency
75 N Country Rd, Port Jefferson, NY 11777
(631) 686-2517 (phone), (631) 476-2774 (fax)
Languages:
English
Description:
Dr. Liu works in Port Jefferson, NY and specializes in Internal Medicine. Dr. Liu is affiliated with John T Mather Memorial Hospital.

Lawyers & Attorneys

Ying Liu Photo 2

Ying Liu - Lawyer

View page
ISLN:
1000807306
Admitted:
2017

Resumes

Resumes

Ying Liu Photo 3

Ying Liu New York, NY

View page
Work:
Rockefeller University
New York, NY
Jan 2011 to Apr 2011
Teaching Assistant and adjunct lecturer

Harvard University
Cambridge, MA
Aug 2005 to Jun 2007
Staff Research Associate

University of California
San Francisco, CA
Dec 2004 to Jul 2005
Staff Research Associate

Education:
Cornell University, Weill Cornell Graduate School of Medical Sciences
New York, NY
2007 to 2014
Ph.D. of Biochemistry in Cell and Molecular Biology

University of Minnesota-Twin Cities
Minneapolis, MN
2002 to 2004
Master of Science in Molecular, Cellular Biology and Genetics

Nankai University
1998 to 2002
BS in Biology

Skills:
Statistical analysis of high-throughput sequencing data, Advanced knowledge of R, UNIX/Linux shell scripting, Data management, Standard stem cell biology assay, Immunohistochemistry assay, Fluorescence-activated cell sorting (FACS) and flow cytometry, Mouse genetics
Ying Liu Photo 4

Ying Liu St. Louis, MO

View page
Work:
University of Missouri - St. Louis

Sep 2006 to 2000
Research assistant

St. Louis Science Center
St. Louis, MO
Aug 2008 to Aug 2010
Staff

Education:
University of Missouri - St. Louis
St. Louis, MO
2006 to 2007
M.A. in Education

Central China Normal University
Wuhan, China
2000 to 2004
B.A. in Education

Ying Liu Photo 5

Ying Liu

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ying Wu Liu
President
Royaltea Beverages Inc
1271 Washington Ave, San Leandro, CA 94577
Ying Liu
President
Legendcast Corp
2525 Van Ness Ave, San Francisco, CA 94109
55 Vis Grande Ave, Daly City, CA 94014
Ying Liu
President
X-Z LAB, Inc.
Public Safety · Testing Laboratory · Whol Electronic Parts/Equipment
2440 Camino Ramon SUITE 264, San Ramon, CA 94583
Ying Bing Liu
President
A&N BIOMED, INC
Nonclassifiable Establishments
550 Hazel Ave, Millbrae, CA 94030
500 Sansome St, San Francisco, CA 94111
Ying Liu
Managing
Global Import & Export, LLC
Import and Export of Misc Goods
3940 Geary Blvd, San Francisco, CA 94118
10192 Park Cir W, Cupertino, CA 95014
Ying Liu
Harloud LC
4403 Amador Rd, Fremont, CA 94538
Ying Liu
Asiabizco, LLC
Consulting/Business Development
4523 Meyer Park Cir, Fremont, CA 94536
Ying Liu
SYT, INC

Publications

Amazon

Dermal Needling Therapy

View page

This book introduces the fundamentals of dermal needling therapy, such as the principles of treatment, characteristics, indications, management of and precautions with accidents during treatment. It supplies the locations and the indications of commonly-used acupuncture points of the fourteen channe...

Author

Zhang Xue-li, Liu Ying

Binding

Hardcover

Pages

302

Publisher

People's Medical Publishing House

ISBN #

7117106360

EAN Code

9787117106368

ISBN #

15

The Harvard Business School Guide to Careers in Finance, 2002

View page

The 2002 edition of The Harvard Business School Guide to Careers in Finance is an indispensable resource for anyone considering a job search in finance or investment banking. This all-in-one guide details the trends in finance, describes the industry's vast and varying career opportunities, and prov...

Author

Harvard Business School Press

Binding

Paperback

Pages

130

Publisher

Harvard Business School Press

ISBN #

1578515807

EAN Code

9781578515806

ISBN #

14

Fuzzy Topology (Advances in Fuzzy Systems: Application and Theory)

View page

Fuzzy set theory provides us with a framework which is wider than that of classical set theory. Various mathematical structures, whose features emphasize the effects of ordered structure, can be developed on the theory. Fuzzy topology is one such branch, combining ordered structure with topological ...

Author

Liu Ying-Ming

Binding

Paperback

Pages

364

Publisher

Wspc

ISBN #

9810228627

EAN Code

9789810228620

ISBN #

7

Paida and Lajin Self-Healing

View page

Paida and Lajin Self-Healing, authored by Hongchi Xiao, introduces you two “green” self-healing methods — Paida (patting and slapping body areas) and Lajin (stretching tendons) that can help you relieve or even self heal diseases and pains without the worry of side effects. It also reveals some of t...

Author

Hongchi Xiao

Binding

Kindle Edition

Pages

190

Publisher

Hongchi Xiao

ISBN #

1

Good Personality Determines the Whole Life of Children (Chinese Edition)

View page

This book written by Liu Ying is a necessary guideline for teenagers in their growing course. It helps them face the physical and psychological changes during the in adolescence properly, develop the consciousness of respecting equality when making friends, and undertake the due moral and social re...

Author

Liu Ying

Binding

Paperback

Pages

201

Publisher

Hunan science and Technology Press

ISBN #

7535775802

EAN Code

9787535775801

ISBN #

5

Nutrition Book for Babies of 0-3 Years (Chinese Edition)

View page

0 -3 years is a critical period for the development of babies, balanced and comprehensive nutrition can provide important protection. According to physical development and nutritional needs of babies of 0 -3 years, the first part introduces the nursing care and feeding guidelines for the parents, an...

Author

Liu Ying

Binding

Paperback

Pages

196

Publisher

Chemical Industry Press

ISBN #

7122158721

EAN Code

9787122158727

ISBN #

4

Us Patents

Mammalian Receptors For Interleukin-10

View page
US Patent:
6423500, Jul 23, 2002
Filed:
Nov 15, 1999
Appl. No.:
09/439672
Inventors:
Kevin W. Moore - Palo Alto CA
Ying Liu - Mountain View CA
Alice Suk-Yue Ho - Milpitas CA
Bazan Fernando J. - Menlo Park CA
Jimmy C. Tan - Edison NJ
Chuan-Chu Chou - Westfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 3353
US Classification:
435 71, 435 792, 435 691, 435 695, 530351, 5303882, 5303892
Abstract:
Receptor components for IL-10 are isolated and characterized. The amino acid sequence and nucleic acid encoding various species variants of the receptors are disclosed. Uses of the purified receptor gene and polypeptide are disclosed, including means for screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies. Therapeutic or diagnostic reagents and kits are also provided.

Method Of Impairing Movement Of A Cla + Memeory T-Cell Within Or To The Skin Of A Mammal By Administering A Ctack Antagonist

View page
US Patent:
6824781, Nov 30, 2004
Filed:
Jul 2, 2001
Appl. No.:
09/898751
Inventors:
Wei Wang - Palo Alto CA
Elizabeth R. Oldham - Mountain View CA
Hortensia Soto - Sunnyvale CA
Ying Liu - Mountain View CA
Susan A. Hudak - Redwood City CA
Bernhard Homey - Palo Alto CA
Janine M. Morales - San Francisco CA
Leslie M. McEvoy - Mountain View CA
Edward P. Bowman - San Carlos CA
Albert Zlotnik - Palo Alto CA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 39395
US Classification:
4241581, 4241301, 514 2, 5303871
Abstract:
Agonists or antagonists of CTACK or Vic chemokines, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the CTACK or Vic chemokines are specifically capable of inducing movement of a skin cell subset. Moreover, matching of ligand with GPR2 receptor in mammals provides methods of use.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
7628986, Dec 8, 2009
Filed:
Jun 25, 2004
Appl. No.:
10/877773
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Foster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver, CA
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
A61K 39/00
A61K 39/395
C07K 16/00
C07K 16/18
C07K 16/28
C12P 21/08
US Classification:
4241301, 4241411, 4241431, 4241781, 4241791, 435810, 5303871, 5303881, 53038815, 53038822, 5303911
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
7736644, Jun 15, 2010
Filed:
Jun 25, 2004
Appl. No.:
10/877774
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Foster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver, CA
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
A61K 39/00
A61K 39/395
C07K 16/00
C07K 16/18
C07K 16/28
C12P 21/08
US Classification:
4241301, 4241421, 4241431, 4241781, 4241811, 4241831, 435 7021, 435810, 5303871, 5303881, 53038815, 53038822, 5303917
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
20090155282, Jun 18, 2009
Filed:
Nov 10, 2008
Appl. No.:
12/268352
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Foster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver, CA
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
A61K 39/395
C12N 5/02
C07H 21/04
US Classification:
4241391, 435375, 536 2353
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
20090156790, Jun 18, 2009
Filed:
Nov 10, 2008
Appl. No.:
12/268363
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Foster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver, CA
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
C07K 16/18
US Classification:
5303879, 53038815
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
20090175887, Jul 9, 2009
Filed:
Mar 2, 2009
Appl. No.:
12/396286
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Foster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver, CA
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
A61K 39/395
C12N 5/06
US Classification:
4241781, 435375
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof

View page
US Patent:
20090240038, Sep 24, 2009
Filed:
Mar 2, 2009
Appl. No.:
12/396313
Inventors:
Richard Weber - San Francisco CA, US
Xiao Feng - Union City CA, US
Orit Foord - Foster City CA, US
Larry Green - San Francisco CA, US
Jean M. Gudas - Santa Monica CA, US
Bruce Keyt - Hillsborough CA, US
Ying Liu - Palo Alto CA, US
Palaniswami Rathanaswami - Vancouver, CA
Robert Raya - Fremont CA, US
Xiao Dong Yang - Palo Alto CA, US
Jose Corvalan - Forster City CA, US
Ian Foltz - Burnaby, CA
Xiao-Chi Jia - Los Angeles CA, US
Jaspal S. Kang - Surrey, CA
Chadwick T. King - Vancouver CA, US
Scott L. Klakamp - Fremont CA, US
Qiaojuan Jane Su - San Jose CA, US
Assignee:
Amgen Fremont Inc. - Fremont CA
International Classification:
C07K 16/18
US Classification:
5303917
Abstract:
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.

Isbn (Books And Publications)

Sprache, Verstehen, Und Ubertragung: Hermeneutische Grundlage Der Philosophischen Ubersetzung

View page
Author

Ying Liu

ISBN #

3631313918

Ying Wei Liu from San Francisco, CA, age ~82 Get Report